Experts from Penn's School of Medicine to present at ACC Annual Scientif...( Penn experts will present research f...),Health
Penn experts will present research findings that could come to define new standards of cardiovascular diagnostics and care at this weekends conference of the American College of Cardiology, the foremost professional society representing heart specialists throughout the world. These experts will gather beginning this weekend in Chicago to present and discuss the latest advances in cardiovascular medicine, science and education.
To arrange interviews with any of these presenters or other Penn physicians who will be in attendance, please call 215-200-2313, or email holly.auer@uphs.upenn.edu. All research results are embargoed until the time they are presented during the conference.
The Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity and Cardiovascular Biomarkers in Patients with Coronary Heart Disease or Risk Equivalent
Emile R. Mohler, MD, Director of Vascular Medicine and Associate Professor of Medicine
10 a.m., Sunday, March 30
Dr. Mohler will present results of a trial that may herald a new class of medications to prevent heart attack and stroke. Researchers at Penn and several other sites around the world studied the safety and efficacy of the drug darapladib (manufactured by GlaxoSmithKline) on Lp-PLA, an enzyme associated with inflammatory activity and increased risk for heart attack and stroke.
The drug was tested among patients already taking a cholesterol-lowering statin drug. After 12 weeks on a daily regimen of 160 mg of darapladib, blood tests revealed a decrease in two important circulating biomarkers, suggesting a possible reduction in systemic inflammatory burden.
While the drug doesnt necessarily act to shrink plaque, Mohler says the research suggests that darapladib may reduce plaque inflammation and therefore lower rates of clot formation and heart attacks among patients with coronary heart disease. <
'/>"/>
| Contact: Holly Auer holly.auer@uphs.upenn.edu 215-200-2313 University of Pennsylvania School of Medicine Source:Eurekalert |
Related medicine news :
1. Infant formula must contain DHA omega-3 and AA omega-6, say international experts
2. Teen Driving Experts at The Childrens Hospital of Philadelphia Support New Recommendations From the New Jersey Teen Driver Study Commission
3. NASI Experts Available to Comment on 2008 Social Security and Medicare Trustees Reports
4. ID, HIV experts urge more resources for TB
5. CMS Approves Home Sleep Testing for Diagnosis of OSA; AASM Experts Available for Comment
6. New England Area Fertility Experts Issue Call for Ethnic Egg Donors
7. Experts call for community mobilization to curb youth violence
8. The Chartis Group Elects New Partners: Four Healthcare Industry Experts Promoted to Principal
9. Experts will analyze the nutrition and health relationship from pregnancy to adolescence
10. Spiritual Health Experts Speak at Chaplains Conference in Pittsburgh March 8-12
11. Experts Delve Into Issues of HPV Vaccination
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |